Evaluation of the Safety and Efficacy of Scheduled Temporary Withdrawal Versus Ongoing Maintenance of Interleukin Inhibitors in Psoriasis Patients: A Systematic Review and Network Meta-Analysis - Quiz - MDSpire

Evaluation of the Safety and Efficacy of Scheduled Temporary Withdrawal Versus Ongoing Maintenance of Interleukin Inhibitors in Psoriasis Patients: A Systematic Review and Network Meta-Analysis

  • By

  • Rodrigo R. de Sena

  • Kleyton de C Mesquita

  • Letícia F. Barroso

  • Paola B. E. Canabrava

  • Fernando Zanghelini

  • Ciro M. Gomes

  • March 18, 2026

  • 0 min

Share

Original Source(s)

Evaluation of the Safety and Efficacy of Scheduled Temporary Withdrawal Versus Ongoing Maintenance of Interleukin Inhibitors in Psoriasis Patients: A Systematic Review and Network Meta-Analysis

  • by Rodrigo R. de Sena, Kleyton de C Mesquita, Letícia F. Barroso, Paola B. E. Canabrava, Fernando Zanghelini, Ciro M. Gomes

  • March 18, 2026

Related Content

Tildrakizumab Enhances Disease Management and Patient-Reported Outcomes in Individuals with Moderate-to-Severe Chronic Plaque Psoriasis: Findings from a Prospective Real-World Investigation

Efficacy of Upadacitinib in Managing Coexisting Psoriasis and Lichen Planus: A Case Study

Efficacy of AVT04, a Biosimilar to Ustekinumab, in Managing Plaque Psoriasis: Findings from a 28-Week Real-World Study